S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Abbott Laboratories

ABT Healthcare
$108.03 $-0.11 (-0.10%)
Market Cap: $187.72 B
Gurus Holding
17
Popularity Rank
#75
% of Shares Held
1.62%
Net Activity (Q4 2025)
-$5.66 M

Guru Ownership Trend

Guru Analysis for Abbott Laboratories (ABT)

Abbott Laboratories (ABT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 17 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.04 B.

Top institutional holders include Ken Fisher and Jeremy Grantham.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.66 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies who opened a new position. Conversely, Robert Bruce reduced exposure by 15.0%.

Key Holders

Top 5 by Value

$1.43 B
$1.06 B
$135.14 M
$88.72 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$137.62 M
Total Buy Value
New Buys 3
Additions 5
-$143.28 M
Total Sell Value
Reductions 8
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
8
Net Buyers
8

FAQs for Abbott Laboratories (ABT)

Major holders include Ken Fisher ($1.43 B), Jeremy Grantham ($1.06 B), Diamond Hill Capital ($647.69 M). According to the latest reported data, 17 tracked investment managers collectively hold approximately 28.13 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.66 M, with 8 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 8 managers trimmed their positions, while 0 fully exited ABT. The total reported sell value was $143.28 M.

Yes, 3 managers opened new positions in ABT, and 5 increased their existing holdings. The total reported buy value was $137.62 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.49% Reduce -4.9% 11,440,255 $1.43 B Q4 2025
2.72% Add 3.7% 8,482,553 $1.06 B Q4 2025
3.32% Reduce -7.8% 5,169,513 $647.69 M Q4 2025
0.07% Reduce -7.0% 1,078,593 $135.14 M Q4 2025
0.85% Reduce -2.1% 708,081 $88.72 M Q4 2025
0.11% New Buy 558,066 $69.92 M Q4 2025
0.04% New Buy 170,337 $21.34 M Q4 2025
0.06% Add 2.9% 122,694 $15.37 M Q4 2025
4.42% Reduce -15.0% 113,800 $14.26 M Q4 2025
0.05% Add 75.2% 113,177 $14.18 M Q4 2025
1.17% Reduce -1.0% 66,477 $8.33 M Q4 2025
0.04% Add 17.6% 60,015 $7.52 M Q4 2025
0.03% Reduce -0.2% 22,308 $2.79 M Q4 2025
0.02% 11,510 $1.44 M Q4 2025
0.02% Reduce -3.9% 10,051 $1.26 M Q4 2025
0.03% New Buy 2,903 $363,718 Q4 2025
0.00% Add 10.3% 171 $21,508 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form